Hyalex Orthopaedics
PrivateLast Round
Series B
Oct 2, 2024
Est. Valuation
$68.9M
Total Funding Raised
$47.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hyalex Orthopaedics is a medical technology company that develops a biomimetic synthetic cartilage platform for the treatment of diseased and damaged joints.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hyalex Orthopaedics Comparables
Compare Hyalex Orthopaedics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sparta Biomedical | 84% | |
| BioPoly LLC | 83% | |
| Askel Healthcare | 78% |
Hyalex Orthopaedics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 2, 2024 | ||||
| Series A Extension | Mar 28, 2019 | ||||
| Series A | May 31, 2017 |
Key People
Founding team and executive leadership
Hyalex Orthopaedics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Osage University Partners | Series A Extension, Series A |
| Canaan Partners | Series A Extension, Series A |
| DSM Venturing | Series A, Series A Extension |
| Johnson & Johnson Innovation – JJDC | Series A Extension, Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A, Series A Extension |
| Treo Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 34% MoM, from 2.2K to 3K.
- Oct 14, 2025
Will present clinical study data at the ICRS Congress 2025.
Hyalex Orthopaedics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hyalex Orthopaedics's valuation, stock price, and market status.
Is Hyalex a public or private company?
Hyalex is a private company.
What is the current stock price of Hyalex?
Hyalex is a private company with no public stock price. No recent secondary market data is available.
How much is Hyalex worth (valuation)?
Valuation information for Hyalex is not publicly available.
Can I buy Hyalex stock?
Hyalex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hyalex's last funding round?
Hyalex's most recent funding round was Series A Extension on March 28, 2019.
Who are the main investors in Hyalex?
Key investors in Hyalex include Canaan Partners, Treo Ventures.
Will Hyalex IPO soon?
No public IPO plans have been announced for Hyalex.
How can I track Hyalex secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hyalex's secondary market activity and sign up for updates.